Altered P-selectin and CD44 expression in the renal tissues and peripheral blood of children with IgA nephropathy

International Urology and Nephrology

Volumn 41, Issue 3, 2009, Pages 703-711

  Qiaoling, Zhang ^a   Xiaoyun, Jiang ^a   Wei, Wu ^a   Shuhong, Dong ^a   Yaqin, Peng ^a   Xiaoqing, Guan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

CD44; Cellular adhesion molecules; Children; IgA nephropathy; P selectin

Indexed keywords

BETA 2 MICROGLOBULIN; HERMES ANTIGEN; LYSOZYME; N ACETYL BETA GLUCOSAMINIDASE; PADGEM PROTEIN;

ADOLESCENT; ALBUMIN BLOOD LEVEL; ANTIGEN EXPRESSION; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INFLAMMATION; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY PARENCHYMA; MALE; PROTEIN URINE LEVEL; PROTEINURIA; SEROLOGY; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; ANTIGENS, CD44; CHILD; CHILD, PRESCHOOL; FEMALE; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY; MALE; P-SELECTIN;

EID: 67650002695     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-008-9512-y     Document Type: Article

References (39)

1. Emancipator SN (1994) IgA nephropathy: Morphologic expression and pathogenesis. Am J Kidney Dis 23:451-462
2. Fujinaga S, Ohtomo Y, Umino D, Mochizuki H, Murakami H, Shimizu T, Yamashiro Y, Kaneko K (2007) Plasma exchange combined with immunosuppressive treatment in a child with rapidly progressive IgA nephropathy. Pediatr Nephrol 22:899-902. doi: 10.1007/s00467-006-0428-4
3. Beerman I, Novak J, Wyatt RJ, Julian BA, Gharavi AG (2007) The genetics of IgA nephropathy. Nat Clin Pract Nephrol 3:325-338. doi: 10.1038/ ncpneph0492
4. Zhang AH, Zhong H, Tang W, Chen SY, He L, Wang S, Su CY, Lu XH, Wang T (2008) Establishing a renal management clinic in China: Initiative, challenges, and opportunities. Int Urol Nephrol 40(4):1053-1058. doi: 10.1007/s11255-008-9450-8
5. James VD, Joseph PG (2002) IgA nephropathy. N Engl J Med 347:738-748. doi: 10.1056/NEJMra020109
6. Maixnerová D, Merta M, Reiterová J, Štekrov J, Ryšav R, Viklicky O, Obeidová H, Tesař V (2008) The influence of two megsin polymorphisms on the progression of IgA nephropathy. Folia Biol (Praha) 54:40-45
7. Lai ASH, Lai KN (2005) Molecular basis of IgA nephropathy. Curr Mol Med 5:475-487. doi: 10.2174/1566524054553450
8. Donadio JV Jr, Grande JP (1997) Immunoglobulin a nephropathy: A clinical perspective. J Am Soc Nephrol 8:1324-1332
9. Yoshikawa N, Ito H, Nakamura H (1992) Prognostic indicators in childhood IgA nephropathy. Nephron 60:60-67. doi: 10.1159/000133296
10. Shenoy M, Ognjanovic MV, Coulthard MG (2007) Treating severe Henoch-Schönlein and IgA nephritis with plasmapheresis alone. Pediatr Nephrol 22:1167-1171. doi: 10.1007/s00467-007-0498-y
11. Barratt J, Feehally J (2006) Treatment of IgA nephropathy. Kidney Int 69:1934-1938. doi: 10.1038/sj.ki.5000419
12. Libetta C, Rampino T, Palumbo G, Esposito C, Dal Canton A (1997) Circulating serum lectins of patients with IgA nephropathy stimulate IL-6 release from mesangial cells. J Am Soc Nephrol 8:208-213
13. Taniguchi Y, Yorioka N, Oda H, Yamakido M (1996) Platelet-derived growth factor, interleukin (IL)-1 beta, IL-6R and tumor necrosis factor-alpha in IgA nephropathy: An immunohistochemical study. Nephron 74:652-660
14. Wagrowska-Danilewicz M, Danilewicz M (2004) Expression of alpha5beta1 and alpha6beta1 integrins in IgA nephropathy (IgAN) with mild and severe proteinuria. an immunohistochemical study. Int Urol Nephrol 36(1):81-87. doi: 10.1023/B:UROL.0000032707.22306.d1
15. Maixnerova D, Merta M, Reiterova J, Štekrova J, Ryšava R, Obeidova H, Viklicky O, Potměšil P, Tesař V (2007) The influence of three endothelin-1 polymorphisms on the progression of IgA nephropathy. Folia Biol (Praha) 53:27-32
16. Adler S, Brady HR (1999) Cell adhesion molecules and the glomerulopathies. Am J Med 107:371-386. doi: 10.1016/ S0002-9343(99)00233-8
17. Ogawa D, Shikata K, Matsuda M, Okada S, Wada J, Yamaguchi S, Suzuki Y, Miyasaka M, Tojo S, Makino H (2002) Preventive effect of sulphated colominic acid on P-selectin-dependent infiltration of macrophages in experimentally induced crescentic glomerulonephritis. Clin Exp Immunol 129:43-53. doi: 10.1046/j.1365-2249.2002.01875.x
18. Watanabe Y, Inoue T, Okada H, Kotaki S, Kanno Y, Kikuta T, Suzuki H (2006) Impact of selectin gene polymorphisms on rapid progression to end-stage renal disease in patients with IgA nephropathy. Intern Med 45:947-951. doi: 10.2169/internalmedicine.45.1641
19. Itoh S, Susuki C, Takeshita K, Nagata K, Tsuji T (2007) Redistribution of P-selectin glycoprotein ligand-1 (PSGL-1) in chemokine-treated neutrophils: A role of lipid microdomains. J Leukoc Biol 81:1-8. doi: 10.1189/jlb.0606398
20. Tang J, Ley KF, Hunt CA (2007) Dynamics of in silico leukocyte rolling, activation, and adhesion. BMC Syst Biol 1:14-38. doi: 10.1186/ 1752-0509-1-14
21. Gironella M, Mollà M, Salas A, Soriano A, Sans M, Closa D, Engel P, Salas A, Piqué JM, Panés J (2002) The role of P-selectin in experimental colitis as determined by antibody immunoblockade and genetically deficient mice. J Leukoc Biol 72:56-64
22. Zhou T, Li X, Hao CL, Fu XL, Yao J, Chen N, Dong DC (1999) Significance of P-selectin expression in IgA nephropathy. Chin J Immunol 15:328-330
23. Gunthert U (1993) CD44: A multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 184:47-63
24. Lesley J, Hyman R, Kincade PW (1993) CD44 and its interaction with extracellular matrix. Adv Immunol 54:271-335. doi: 10.1016/ S0065-2776(08)60537-4
25. Wüthrich RP (1999) The proinflammatory role of hyaluronan-CD44 interactions in renal injury. Nephrol Dial Transplant 14:2554-2556. doi: 10.1093/ndt/14.11.2554
26. Siegelman MH, DeGrendele HC, Estess P (1999) Activation and interaction of CD44 and hyaluronan in immunological systems. J Leukoc Biol 66:315-321
27. Roy-Chaudhury P, Khong TF, Williams JH, Haites NE, Wu B, Simpson JG, Power DA (1996) CD44 in glomerulonephritis: Expression in human renal biopsies, the Thy 1.1 model, and by cultured mesangial cells. Kidney Int 50:272-281. doi: 10.1038/ki.1996.312
28. Florquin S, Nunziata R, Claessen N, van den Berg FM, Pals ST, Weening JJ (2002) CD44 expression in IgA nephropathy. Am J Kidney Dis 39:407-414. doi: 10.1053/ajkd.2002.30563
29. Yang JY, Cheng SM, Yao Y, Ding J (2001) Clinical classification, diagnosis and treatment of glomerular diseases in children. Chin J Pediatr 39:746-747
30. Wang HY (ed) (1996) Nephrology. People's Medical Publishing House, Beijing
31. Oda T, Kimura M, Hishida A, Yamashita A, Suzuki Y, Miyasaka M (1998) Cell-to-cell interaction is required to induce proteinuria in situ immune complexes glomerulonephritis. J Lab Clin Med 132:112-116. doi: 10.1016/S0022-2143(98)90006-3
32. Bourguignon LY, Gilad E, Peyrollier K, Brightman A, Swanson RA (2007) Hyaluronan-CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes. J Neurochem 101(4):1002-1017. doi: 10.1111/ j.1471-4159.2007.04485.x
33. Wang SJ, Peyrollier K, Bourguignon LY (2007) The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer. Arch Otolaryngol Head Neck Surg 133(3):281-288. doi: 10.1001/archotol.133.3.281
34. Ponta H, Sherman L, Herrlich PA (2003) CD44: From adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4:33-45. doi: 10.1038/ nrm1004
35. Desai B, Rogers MJ, Chellaiah MA (2007) Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells. Molecular Cancer 6:18-34
36. Wuthrich RP (1999) The proinflammatory role of hyaluronan-CD44 interactions in renal injury. Nephrol Dial Transplant 14:2554-2556. doi: 10.1093/ndt/14.11.2554
37. Wagrowska-Danilewicz M, Danilewicz M (2002) A correlation between immunoexpression of CD44, alpha-SMA and CD68+ cells in IgA-nephropathy and in mesangial proliferative IgA-negative glomerulonephritis. Pol J Pathol 53:155-162
38. Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP (1997) Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 8:199-207
39. Coppo R, D'Amico G (2005) Factors predicting progression of IgA nephropathies. J Nephrol 18:503-512